From Naturally-Sourced Protease Inhibitors to New Treatments for Fungal Infections

被引:21
作者
Gutierrez-Gongora, Davier [1 ,2 ]
Geddes-McAlister, Jennifer [1 ,3 ]
机构
[1] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada
[2] Univ La Habana, Fac Biol, Ctr Estudio Prot, Havana 10400, Cuba
[3] Canadian Prote & Artificial Intelligence Res & Tr, Guelph, ON N1G 2W1, Canada
基金
加拿大创新基金会; 加拿大健康研究院;
关键词
proteases; protease inhibitors; fungal pathogens; natural compounds; biomedical applications; antimicrobial resistance; CANDIDA-ALBICANS; SERINE-PROTEASE; TRYPSIN-INHIBITOR; PROTEOLYTIC-ENZYMES; HIV-1; PROTEASE; CRYPTOCOCCUS-NEOFORMANS; ANTIMICROBIAL ACTIVITY; PROTEINASE-INHIBITOR; ANTIFUNGAL ACTIVITY; CRYSTAL-STRUCTURE;
D O I
10.3390/jof7121016
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Proteases are involved in a broad range of physiological processes, including host invasion by fungal pathogens, and enzymatic inhibition is a key molecular mechanism controlling proteolytic activity. Importantly, inhibitors from natural or synthetic sources have demonstrated applications in biochemistry, biotechnology, and biomedicine. However, the need to discover new reservoirs of these inhibitory molecules with improved efficacy and target range has been underscored by recent protease characterization related to infection and antimicrobial resistance. In this regard, naturally-sourced inhibitors show promise for application in diverse biological systems due to high stability at physiological conditions and low cytotoxicity. Moreover, natural sources (e.g., plants, invertebrates, and microbes) provide a large reservoir of undiscovered and/or uncharacterized bioactive molecules involved in host defense against predators and pathogens. In this Review, we highlight discoveries of protease inhibitors from environmental sources, propose new opportunities for assessment of antifungal activity, and discuss novel applications to combat biomedically-relevant fungal diseases with in vivo and clinical purpose.
引用
收藏
页数:13
相关论文
共 110 条
  • [11] Benkendorff K., 2014, NEUROECOLOGY NEUROET, P13
  • [12] Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs
    Bien, Clara M.
    Chang, Yun C.
    Nes, W. David
    Kwon-Chung, Kyung J.
    Espenshade, Peter J.
    [J]. MOLECULAR MICROBIOLOGY, 2009, 74 (03) : 672 - 690
  • [13] The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans
    Blasi, E
    Colombari, B
    Orsi, CF
    Pinti, M
    Troiano, L
    Cossarizza, A
    Esposito, R
    Peppoloni, S
    Mussini, C
    Neglia, R
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 42 (02): : 187 - 195
  • [14] Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds
    Bondaryk, Malgorzata
    Staniszewska, Monika
    Zielinska, Paulina
    Urbanczyk-Lipkowska, Zofia
    [J]. JOURNAL OF FUNGI, 2017, 3 (03)
  • [15] HIV-1 protease: mechanism and drug discovery
    Brik, A
    Wong, CH
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2003, 1 (01) : 5 - 14
  • [16] Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans
    Cadicamo, Cosimo D.
    Mortier, Jeremie
    Wolber, Gerhard
    Hell, Marie
    Heinrich, Ina E.
    Michel, Dana
    Semlin, Lydia
    Berger, Ursula
    Korting, Hans C.
    Hoeltje, Hans-Dieter
    Koksch, Beate
    Borelli, Claudia
    [J]. BIOCHEMICAL PHARMACOLOGY, 2013, 85 (07) : 881 - 887
  • [17] Apoptosis in yeast: triggers, pathways, subroutines
    Carmona-Gutierrez, D.
    Eisenberg, T.
    Buettner, S.
    Meisinger, C.
    Kroemer, G.
    Madeo, F.
    [J]. CELL DEATH AND DIFFERENTIATION, 2010, 17 (05) : 763 - 773
  • [18] In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors
    Cassone, A
    De Bernardis, F
    Torosantucci, A
    Tacconelli, E
    Tumbarello, M
    Cauda, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) : 448 - 453
  • [19] Extracellular proteinase activity of Cryptococcus neoformans
    Chen, LC
    Blank, ES
    Casadevall, A
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (05) : 570 - 574
  • [20] Extracellular proteins of Cryptococcus neoformans and host antibody response
    Chen, LC
    Pirofski, LA
    Casadevall, A
    [J]. INFECTION AND IMMUNITY, 1997, 65 (07) : 2599 - 2605